Evidence map›Paper›PMID 40980664›Full record

ReviewKidney international reports2025

Cardiovascular Complications in ADPKD.

Niloufar Ebrahimi, Yasar Caliskan, Pranav S Garimella, Sol Carriazo, Fouad T Chebib, Giv Heidari Bateni, Neera K Dahl, Anjay Rastogi, Amir Abdipour, Sayna Norouzi

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Niloufar EbrahimiDepartment of Medicine, Division of Nephrology, Loma Linda University Medical Center, Loma Linda, California, USA.
Yasar CaliskanSaint Louis University Center for Abdominal Transplantation, Saint Louis University, St. Louis, Missouri, USA.
Pranav S GarimellaDivision of Nephrology and Hypertension, Department of Medicine, University of California San Diego, San Diego, California, USA.
Sol CarriazoDivision of Nephrology, University Health Network, Toronto, Ontario, Canada.
Fouad T ChebibDivision of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida, USA.
Giv Heidari BateniDivision of Cardiology, Arrowhead Regional Medical Center, California University of Science and Medicine, California, USA.
Neera K DahlDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
Anjay RastogiDepartment of Medicine, University of California Los Angeles, Los Angeles, California, USA.
Amir AbdipourDepartment of Medicine, Division of Nephrology, Loma Linda University Medical Center, Loma Linda, California, USA.
Sayna NorouziDepartment of Medicine, Division of Nephrology, Loma Linda University Medical Center, Loma Linda, California, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autosomal dominant polycystic kidney disease (ADPKD), primarily caused by mutations in the

Indexed as

autosomal dominant polycystic kidney diseasecardiovascular complicationshypertensionleft ventricular hypertrophyvalvular abnormalities

Identifiers

PMID40980664
PMCPMC12446925

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.